EE143 Cost-Effectiveness of Ofatumumab Compared with Other Disease-Modifying Therapies for the Treatment of Relapsing Multiple Sclerosis in Greece
Abstract
Authors
A Petropoulos P Cooney M Patidar K Gudala S Tiwari R Brennan K Kapsogeorgiou G Cheilas J Banhazi